186 related articles for article (PubMed ID: 34242567)
1. The interaction of disulfiram and H
Read E; Milford J; Zhu J; Wu L; Bilodeau M; Yang G
Toxicol Appl Pharmacol; 2021 Sep; 426():115642. PubMed ID: 34242567
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of cystathionine-β-synthase inhibition by disulfiram: The role of bis(N,N-diethyldithiocarbamate)-copper(II).
Zuhra K; Panagaki T; Randi EB; Augsburger F; Blondel M; Friocourt G; Herault Y; Szabo C
Biochem Pharmacol; 2020 Dec; 182():114267. PubMed ID: 33035509
[TBL] [Abstract][Full Text] [Related]
3. Disulfiram's anti-cancer activity reflects targeting NPL4, not inhibition of aldehyde dehydrogenase.
Skrott Z; Majera D; Gursky J; Buchtova T; Hajduch M; Mistrik M; Bartek J
Oncogene; 2019 Oct; 38(40):6711-6722. PubMed ID: 31391554
[TBL] [Abstract][Full Text] [Related]
4. Disulfiram modulates stemness and metabolism of brain tumor initiating cells in atypical teratoid/rhabdoid tumors.
Choi SA; Choi JW; Wang KC; Phi JH; Lee JY; Park KD; Eum D; Park SH; Kim IH; Kim SK
Neuro Oncol; 2015 Jun; 17(6):810-21. PubMed ID: 25378634
[TBL] [Abstract][Full Text] [Related]
5. Disulfiram, an alcohol dependence therapy, can inhibit the in vitro growth of Francisella tularensis.
Hamblin KA; Flick-Smith H; Barnes KB; Pereira-Leal JB; Surkont J; Hampson R; Atkins HS; Harding SV
Int J Antimicrob Agents; 2019 Jul; 54(1):85-88. PubMed ID: 31029736
[TBL] [Abstract][Full Text] [Related]
6. Inactivation of Aldehyde Dehydrogenase by Disulfiram in the Presence and Absence of Lipoic Acid or Dihydrolipoic Acid: An in Vitro Study.
Bilska-Wilkosz A; Górny M; Iciek M
Biomolecules; 2019 Aug; 9(8):. PubMed ID: 31426424
[TBL] [Abstract][Full Text] [Related]
7. Two clinical drugs deubiquitinase inhibitor auranofin and aldehyde dehydrogenase inhibitor disulfiram trigger synergistic anti-tumor effects in vitro and in vivo.
Huang H; Liao Y; Liu N; Hua X; Cai J; Yang C; Long H; Zhao C; Chen X; Lan X; Zang D; Wu J; Li X; Shi X; Wang X; Liu J
Oncotarget; 2016 Jan; 7(3):2796-808. PubMed ID: 26625200
[TBL] [Abstract][Full Text] [Related]
8. Targeting ALDH1A1 by disulfiram/copper complex inhibits non-small cell lung cancer recurrence driven by ALDH-positive cancer stem cells.
Liu X; Wang L; Cui W; Yuan X; Lin L; Cao Q; Wang N; Li Y; Guo W; Zhang X; Wu C; Yang J
Oncotarget; 2016 Sep; 7(36):58516-58530. PubMed ID: 27542268
[TBL] [Abstract][Full Text] [Related]
9. Disulfiram modulates ROS accumulation and overcomes synergistically cisplatin resistance in breast cancer cell lines.
Yang Z; Guo F; Albers AE; Sehouli J; Kaufmann AM
Biomed Pharmacother; 2019 May; 113():108727. PubMed ID: 30870721
[TBL] [Abstract][Full Text] [Related]
10. Disulfiram targets cancer stem-like properties and the HER2/Akt signaling pathway in HER2-positive breast cancer.
Kim JY; Cho Y; Oh E; Lee N; An H; Sung D; Cho TM; Seo JH
Cancer Lett; 2016 Aug; 379(1):39-48. PubMed ID: 27238567
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effect on ovarian cancer ALDH+ stem-like cells by Disulfiram and Copper treatment through ALDH and ROS modulation.
Guo F; Yang Z; Kulbe H; Albers AE; Sehouli J; Kaufmann AM
Biomed Pharmacother; 2019 Oct; 118():109371. PubMed ID: 31545281
[TBL] [Abstract][Full Text] [Related]
12. Disulfiram overcomes bortezomib and cytarabine resistance in Down-syndrome-associated acute myeloid leukemia cells.
Bista R; Lee DW; Pepper OB; Azorsa DO; Arceci RJ; Aleem E
J Exp Clin Cancer Res; 2017 Feb; 36(1):22. PubMed ID: 28143565
[TBL] [Abstract][Full Text] [Related]
13. Disulfiram's Anticancer Activity: Evidence and Mechanisms.
Jiao Y; Hannafon BN; Ding WQ
Anticancer Agents Med Chem; 2016; 16(11):1378-1384. PubMed ID: 27141876
[TBL] [Abstract][Full Text] [Related]
14. Anti-hepatocellular carcinoma properties of the anti-alcoholism drug disulfiram discovered to enzymatically inhibit the AMPK-related kinase SNARK in vitro.
Goto K; Kato N; Chung RT
Oncotarget; 2016 Nov; 7(46):74987-74999. PubMed ID: 27602492
[TBL] [Abstract][Full Text] [Related]
15. S-methyl-N,N-diethylthiocarbamate sulfoxide and S-methyl-N,N-diethylthiocarbamate sulfone, two candidates for the active metabolite of disulfiram.
Mays DC; Nelson AN; Lam-Holt J; Fauq AH; Lipsky JJ
Alcohol Clin Exp Res; 1996 May; 20(3):595-600. PubMed ID: 8727261
[TBL] [Abstract][Full Text] [Related]
16. Differential Cytotoxicity Mechanisms of Copper Complexed with Disulfiram in Oral Cancer Cells.
Chen SY; Chang YL; Liu ST; Chen GS; Lee SP; Huang SM
Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33918312
[TBL] [Abstract][Full Text] [Related]
17. In vivo inhibition of aldehyde dehydrogenase by disulfiram.
Lipsky JJ; Shen ML; Naylor S
Chem Biol Interact; 2001 Jan; 130-132(1-3):93-102. PubMed ID: 11306034
[TBL] [Abstract][Full Text] [Related]
18. Disulfiram Acts as a Potent Radio-Chemo Sensitizer in Head and Neck Squamous Cell Carcinoma Cell Lines and Transplanted Xenografts.
Yao W; Qian X; Ochsenreither S; Soldano F; DeLeo AB; Sudhoff H; Oppel F; Kuppig A; Klinghammer K; Kaufmann AM; Albers AE
Cells; 2021 Feb; 10(3):. PubMed ID: 33671083
[TBL] [Abstract][Full Text] [Related]
19. Differences in the kinetic properties and sensitivity to inhibitors of human placental, erythrocyte, and major hepatic aldehyde dehydrogenase isoenzymes.
Zorzano A; Herrera E
Biochem Pharmacol; 1990 Mar; 39(5):873-8. PubMed ID: 2310412
[TBL] [Abstract][Full Text] [Related]
20. Disulfiram/copper targets stem cell-like ALDH
Jin N; Zhu X; Cheng F; Zhang L
J Cell Biochem; 2018 Aug; 119(8):6882-6893. PubMed ID: 29665144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]